Find clinical trials for Breast Cancer in Charlotte, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Charlotte, NC, USA:
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Charlotte, North Carolina, United States and 10 other locations
in locally advanced unresectable or metastatic triple-negative breast cancer.The main questions it aims to answer are:* to evaluate...
Phase 2
Charlotte, North Carolina, United States
postmenopausal patients with HR-positive, HER2-negative metastatic breast cancer. Pre- and perimenopausal women must receive therap...
Phase 2
Charlotte, North Carolina, United States
This is a Phase 1/2 dose escalation and cohort expansion study and will assess the safety, tolerability and anti-tumor activity of ARV-471 a ...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 15 other locations
works in treating patients with HER2 positive or triple negative breast cancer when image-guided biopsy shows no residual cancer...
Charlotte, North Carolina, United States and 7 other locations
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with breast cancer. The study is designed...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 27 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Charlotte, North Carolina, United States and 225 other locations
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...
Phase 3
Charlotte, North Carolina, United States and 805 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Charlotte, North Carolina, United States and 275 other locations
receptor-low/HER2-negative breast cancer....
Phase 3
Charlotte, North Carolina, United States and 353 other locations
Clinical trials
Research sites
Resources
Legal